Genmab | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Agios Pharmaceuticals USD 10.75M 3.11M 2025-06
Almirall EUR 191.9M 185.49M 2025-03
Amarin USD 25.13M 1.78M 2025-03
Amgen USD 6.17B 624M 2025-06
argenx SE USD 837.21M 127.34M 2025-06
AstraZeneca USD 11.98B 637M 2025-06
Bayer EUR 6.38B 1.74B 2025-06
BioMarin Pharmaceutical USD 670.47M 76.89M 2025-06
Demant DKK 8.55B 33M 2025-06
Exelixis USD 548.79M 12.52M 2025-06
Fresenius Medical Care EUR 1.22B 31M 2025-06
Galapagos EUR 61.25M 98.68M 2025-03
Genmab DKK 868M 195M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
GN Store Nord DKK 2.31B 123M 2025-06
GRIFOLS EUR 743.8M 49.13M 2025-06
Hikma Pharmaceutical USD 692M 64M 2024-12
Insmed USD 78.08M 6.53M 2025-06
Lonza CHF 1.04B 72M 2024-12
Merck EUR 3.03B 118M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.74B 26M 2025-06
UCB EUR 2.46B 520M 2024-12


Genmab Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.